Elevance Health (STU:A58) Cyclically Adjusted Revenue per Share: €586.59 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:A58 Elevance Health Inc STU:A58
85 GF Score
Price €331.90
GF Value €430.28
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Elevance Health Cyclically Adjusted Revenue per Share?

Elevance Health STU:A58 85 Cyclically Adjusted Revenue per Share is €586.59 as of Jun. 2026. GuruFocus rates STU:A58 with a GF Score™ of 85/100 and a GF Value™ of €430.28 (Modestly Undervalued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Elevance Health's adjusted revenue per share for the three months ended in Jun. 2026 was €201.062. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €586.59 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Elevance Health's average Cyclically Adjusted Revenue Growth Rate was 11.90% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 11.80% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 13.90% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 13.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Elevance Health was 16.00% per year. The lowest was 11.80% per year. And the median was 13.20% per year.

As of today (2026-07-27), Elevance Health's current stock price is €331.90. Elevance Health's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was €586.59. Elevance Health's Cyclically Adjusted PS Ratio of today is 0.57.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Elevance Health was 1.29. The lowest was 0.46. And the median was 0.97.


Elevance Health  (STU:A58) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Elevance Health's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=331.90/586.59
=0.57

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Elevance Health was 1.29. The lowest was 0.46. And the median was 0.97.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Elevance Health Cyclically Adjusted Revenue per Share Related Terms


Elevance Health Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Elevance Health's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Elevance Health Cyclically Adjusted Revenue per Share Chart

Elevance Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 338.02 413.67 452.10 538.58 523.94

Elevance Health Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 507.82 515.08 523.94 563.42 586.59

STU:A58 vs CI, HUM, CNC: Cyclically Adjusted Revenue per Share Comparison

For the Healthcare Plans subindustry, Elevance Health's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Elevance Health Cyclically Adjusted PS Ratio vs Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, Elevance Health's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Elevance Health's Cyclically Adjusted PS Ratio falls into.


STU:A58
85GF Score
Elevance Health Inc STU:A58
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Elevance Health Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Elevance Health's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=201.062/333.9520*333.9520
=201.062

Current CPI (Jun. 2026) = 333.9520.

Elevance Health Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 71.133 241.428 98.394
201612 76.611 241.432 105.969
201703 77.891 243.801 106.693
201706 73.643 244.955 100.399
201709 70.470 246.819 95.348
201712 72.872 246.524 98.716
201803 69.549 249.554 93.070
201806 74.254 251.989 98.406
201809 75.080 252.439 99.323
201812 89.637 251.233 119.150
201903 83.223 254.202 109.332
201906 86.350 256.143 112.581
201909 93.154 256.759 121.160
201912 95.643 256.974 124.293
202003 104.552 258.115 135.271
202006 101.748 257.797 131.805
202009 104.064 260.280 133.519
202012 104.096 260.474 133.461
202103 109.603 264.877 138.185
202106 113.566 271.696 139.588
202109 123.775 274.310 150.687
202112 131.817 278.802 157.892
202203 141.531 287.504 164.396
202206 150.147 296.311 169.220
202209 166.550 296.808 187.393
202212 156.208 296.797 175.763
202303 164.325 301.836 181.810
202306 169.509 305.109 185.533
202309 169.765 307.789 184.196
202312 165.990 306.746 180.712
202403 167.254 312.332 178.832
202406 173.724 314.175 184.660
202409 174.499 315.301 184.821
202412 188.029 315.605 198.960
202503 199.050 319.799 207.859
202506 191.124 322.561 197.873
202509 193.142 324.800 198.584
202512 191.715 324.054 197.571
202603 196.944 330.213 199.174
202606 201.062 333.952 201.062

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of €586.59 mean?
Elevance Health (STU:A58) has a Cyclically Adjusted Revenue per Share of €586.59 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Elevance Health and its competitors.
Is Elevance Health's Cyclically Adjusted Revenue per Share too high?
Elevance Health's current Cyclically Adjusted Revenue per Share is €586.59. Overall, Elevance Health has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Elevance Health's Cyclically Adjusted Revenue per Share compare to CI and HUM?
Elevance Health's Cyclically Adjusted Revenue per Share of €586.59 can be compared against companies in the Healthcare Plans industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Healthcare Plans company?
A good Cyclically Adjusted Revenue per Share depends on the Healthcare Plans industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Elevance Health and its competitors. Elevance Health's current Cyclically Adjusted Revenue per Share is €586.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Elevance Health stock overvalued right now?
Based on GuruFocus' analysis, Elevance Health (STU:A58) is currently considered Modestly Undervalued. The stock's GF Value™ is €430.28, compared to a current price of €331.90 — trading 22.9% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is €586.59. Elevance Health's overall GF Score™ is 85/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Elevance Health (STU:A58), the current Cyclically Adjusted Revenue per Share is €586.59 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Elevance Health (STU:A58) Overvalued in 2026?

Based on GuruFocus' analysis, Elevance Health stock appears to be undervalued. The current stock price of €331.90 is trading 22.9% below its estimated GF Value™ of €430.28. GuruFocus considers Elevance Health to be Modestly Undervalued.

Key valuation signals for STU:A58:

  • Cyclically Adjusted Revenue per Share: €586.59
  • GF Value™: €430.28 vs. price of €331.90 (22.9% below fair value)
  • GF Score™: 85/100 with 5 warning signs

No single metric tells the full story. See the STU:A58 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Elevance Health Business Description

Address 220 Virginia Avenue, Indianapolis, IN, USA, 46204
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
85GF Score

Get the complete analysis for STU:A58

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€331.90
Price
€430.28
GF Value